Welltower

Acquisitions And Fund Launch Will Test And Support REIT Resilience

AnalystLowTarget

Not Invested

Consensus Narrative from 19 Analysts

Published

19 Apr 25

Updated

23 Jul 25

AnalystLowTarget's Fair Value

US$145.00

12.3% overvalued

23 Jul

US$162.90

40.5%

-3.1%

Author's Valuation

US$145.0

12.3% overvalued

AnalystLowTarget Fair Value

Narrative

Updates2

Shared on07 May 25
Fair value Increased 8.21%

Shared on30 Apr 25
Fair value Decreased 6.38%

AnalystLowTarget Fair Value

US$145.0

12.3% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

14.25%

Health Care REITs revenue growth rate

0.38%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.11%

Calculation

US$1.54b

Earnings '28

91.91x

PE Ratio '28

US$141.12b

Market Cap '28

US$141.12b

Market Cap '28

801.12m

No. shares '28

US$176.16

Share Price '28

US$176.16 Share Price '28

Discounted to 2025 @ 6.71% p.a.

US$144.98

Fair Value '25

Acquisitions And Fund Launch Will Test And Support REIT Resilience

Shared on07 May 25Fair value Increased 8.21%

Shared on30 Apr 25Fair value Decreased 6.38%

Shared on07 May 25
Fair value Increased 8.21%

Shared on30 Apr 25
Fair value Decreased 6.38%